Pentoxifylline is used to improve blood flow and reduce pain and cramping in the legs caused by poor circulation. It helps people with claudication (pain when walking) walk farther without discomfort.[2] Trental is currently approved and in use across 60 indications[4].[1]
Trental is one of 1036 small molecule programs targeting Non-Small Cell Lung Cancer. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
744 competitors in Breast Cancer
Trental
Lexiscan
Voltaren
Zolymbus
Blenoxane
Methylthioninium Chloride
MS Contin
Duragesic-100
MS Contin
Spravato
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Aug 30, 1984
TRENTAL
NDA NDA018631
Sources
Details